Isocitrate Dehydrogenase Active Not Recruiting Phase 3 Trials for Enasidenib (DB13874)

IndicationStatusPhase
DBCOND0078622 (Isocitrate Dehydrogenase)Active Not Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02577406An Efficacy and Safety Study of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 MutationTreatment